New drugs are being tested and approved almost yearly. For example, Zeposia (ozanimod) was approved by the Food and Drug Administration (FDA) in May 2021 for treatment of moderate to severe active ulcerative colitis in adults. The FDA approved Xeljanz (tofacitinib) for that purpose in May 2018. Talk with your physician about the best options and ask about what new and forthcoming treatments.